27 11, 2023

Amphastar Pharmaceuticals, Inc. Powers Higher Towards Its August 9 All-Time High: Jump in Right Now?

By |2023-11-27T17:22:21+00:00November 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , |

By Leslie N. Masonson, MBA Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH), is a bio-pharmaceutical firm, that develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products to its customers  in the United States, China, and France.  The company was incorporated in 1996 in Rancho Cucamonga, California where it is currently headquartered. It has [...]

Read More
27 06, 2023

One Analyst Predicts Canopy Growth is Headed to Zero, Should You Cut Losses and Move On?

By |2023-08-02T19:10:23+00:00June 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

At one point, Canopy Growth (CGC) was valued at $19 billion. The stock traded at over $50/share at its peak. But today? It sits at a mere $0.49/share. And as dramatic a fall from grace as this story already is, one analyst expects the true end is near. Benchmark analyst Mike Hickey believes Canopy [...]

Read More
27 06, 2023

One Analyst Predicts Canopy Growth is Headed to Zero, Should You Cut Losses and Move On?

By |2023-06-27T13:08:46+00:00June 27th, 2023|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , |

At one point, Canopy Growth (CGC) was valued at $19 billion. The stock traded at over $50/share at its peak. But today? It sits at a mere $0.49/share. And as dramatic a fall from grace as this story already is, one analyst expects the true end is near. Benchmark analyst Mike Hickey believes Canopy [...]

Read More
Go to Top